| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
2e-11 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-09 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
2e-08 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
3e-08 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
3e-08 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |